To determine whether elevated glycolysis is mechanistically responsible for the impaired SOCS3 secretion by AMs from tumor-bearing lungs, we treated the cells with the unmetabolizable glucose analog 2-DG to inhibit glycolysis and subsequently measured SOCS3 levels in their CM. Here, SOCS3 is linked to neoplasm.